The purpose of this study is to determine whether percutaneous coronary angioplasty with Taxus drug eluting stent is safe and effective in the treatment of unprotected left main coronary artery disease associated to other coronary lesions or not.
Coronary artery bypass graft is the reference treatment of left main coronary artery disease. With the advancements of technology and particularly drug-eluting stents, in-stent restenosis has dramatically decreased and now it is possible to extend indications of complexes lesions such as left main coronary artery stenoses. In these particular situations,some centers performed percutaneous coronary angioplasty (PCI) with drug-eluting stents with acceptable results in terms of safety and efficacy. However, these procedures are performed at isolated sites and are not evaluated in multicenter trial.The aim of this study is to assess the safety and efficacy of this PCI with Taxus-stent in a french multicenter trial and to evaluate clinical and angiographic outcome of these patients at long-term follow-up.
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
155
Polyclinique du Parc Rambot
Aix-en-Provence, France
Coronarography
Time frame: 9 months
Major cardio-vascular events
Time frame: 1, 18 and 36 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Clinique Rhône Durance
Avignon, France
Clinique Saint Augustin
Bordeaux, France
Chu Brest
Brest, France
CHU CAEN
Caen, France
Hôpital Cardiologique
Lille, France
Clinique du Tonkin
Lyon, France
Unité Cardio-Vasculaire
Marseille, France
CHU NORD
Marseille, France
Institut Hospitalier Jacques Cartier-ICPS
Massy, France
...and 16 more locations